3D-Printed Coaxial Hydrogel Patches with Mussel-Inspired Elements for Prolonged Release of Gemcitabine

• Published in: Polymers Vol. 13; no. 24; p. 4367
• Main Authors: Talebian, Sepehr, Shim, In Kyong, Foroughi, Javad, Orive, Gorka, Vine, Kara L, Kim, Song Cheol, Wallace, Gordon G
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 13.12.2021; MDPI
• Subjects: 3-D printers; 3D printing; Alginates; Aqueous solutions; Biocompatibility; Biopolymers; Breast cancer; Calcium carbonate; cancer; Dopamine; drug delivery; Drug delivery systems; Drugs; Ethanol; hydrogel; Hydrogels; Mechanical properties; Pancreatic cancer; Patches (structures); Polylactic acid; Polymers; Pore size; Rheology; Shear strain; Swelling ratio; Three dimensional printing; Toxicity testing; Tumors; Viscosity; Australia; cancer; drug delivery; hydrogel; 3D printing
• ISSN: 2073-4360; 2073-4360
• DOI: 10.3390/polym13244367

With the aim of fabricating drug-loaded implantable patches, a 3D printing technique was employed to produce novel coaxial hydrogel patches. The core-section of these patches contained a dopamine-modified methacrylated alginate hydrogel loaded with a chemotherapeutic drug (Gemcitabine), while their shell section was solely comprised of a methacrylated alginate hydrogel. Subsequently, these patches were further modified with CaCO cross linker and a polylactic acid (PLA) coating to facilitate prolonged release of the drug. Consequently, the results showed that addition of CaCO to the formula enhanced the mechanical properties of the patches and significantly reduced their swelling ratio as compared to that for patches without CaCO . Furthermore, addition of PLA coating to CaCO -containing patches has further reduced their swelling ratio, which then significantly slowed down the release of Gemcitabine, to a point where 4-layered patches could release the drug over a period of 7 days in vitro. Remarkably, it was shown that 3-layered and 4-layered Gemcitabine loaded patches were successful in inhibiting pancreatic cancer cell growth for a period of 14 days when tested in vitro. Lastly, in vivo experiments showed that gemcitabine-loaded 4-layered patches were capable of reducing the tumor growth rate and caused no severe toxicity when tested in mice. Altogether, 3D printed hydrogel patches might be used as biocompatible implants for local delivery of drugs to diseased site, to either shrink the tumor or to prevent the tumor recurrence after resection.